november AG

euro adhoc: november AG
Management of november AG strengthened with Appointment of New CFO

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@


Erlangen, 20 September 2005. The Supervisory Board of  november AG today appointed with immediate effect Astrid Dickert, Bachelor of Commerce, as Chief  Financial Officer (CFO) of the company. The core areas of her responsibility and authority will be accounting, controlling, investor relations and human resources.

Ms Dickert joined november AG in 2000 as staff accountant, was promoted in  2003 to Director of Accounting and Controlling and since June of this year headed the complete Financial Department.

Explanations: "The Supervisory Board of november AG, based its decision on its trust in the strong background and experience of Ms Dickert, in deciding for in-house talent to fill the vacant position. With this action, november AG complies with requests of its investors and promotes a more efficient further restructuring into a bio- and nanotechnology holding company for more transparency. With this new appointment, the CFO will attend to the capital markets and coordinate the M&A activity of the Company in a more effective way", stated Dr. Wolf M. Bertling, CEO of november AG.

november AG,  Erlangen, Germany, is listed at the Prime Standard of the Frankfurt Stock Exchange, ISIN DE0006762909, symbol (NBX). November AG is a Bio- and Nanotechnology holding company that develops and invests in new technologies. The group comprises among others the subsidiaries identif GmbH (brand protection & product safety), directif GmbH (Medtech, diagnostics of nucleic acids) and PEQLAB Biotechnologie GmbH (the link between research in molecular biology and the market).

@@start.t2@@end of announcement                                                 euro adhoc 20.09.2005 14:10:30

ots Originaltext: november AG
Im Internet recherchierbar:

Further inquiry note:
Andrea Steuer
Manager Investor Relations/Public Relations
Tel.: +49(0)9131-75088-868
Fax: +49 (0)9131-75088-999

Branche: Biotechnology
ISIN:      DE0006762909
WKN:        676290
Index:    CDAX, Technologie All Share, Prime All Share, Prime Standard
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Berliner Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade

Weitere Meldungen: november AG

Das könnte Sie auch interessieren: